World Health Organization (WHO) says it is working with national health authorities across Africa to bolster surveillance and laboratory diagnosis to detect monkeypox cases and deter a silent spread of the virus.
Although three African countries with no previous history of human monkeypox transmission reporting cases, the continent has, as of 28 June, reported 1821 cases in 13 countries.
The here countries are Ghana, Morocco and South Africa, which has confirmed the disease in two patients with no travel history, suggesting there is a high possibility of local transmission.
109 cases are laboratory confirmed in nine countries, WHO says.
The number of confirmed cases accounts for 2% of the more than 4500 confirmed cases globally.
However, according to the organization, there are a large number of suspected cases in the region, 81% of which are in the Democratic Republic of the Congo, underlining the need for increased diagnostic capacity.
While all African countries have the polymerase chain reaction machines needed to test for monkeypox thanks to reinforced laboratory capacity in the wake of COVID-19, many lack reagents and in some cases training in specimen collection, handling and testing.
WHO is working to secure 60 000 tests for Africa, with around 2000 tests and reagents to be shipped to high-risk countries and 1000 to those facing lower risk.
Over the past month five more African countries have received donations of reagents from partners, bringing to 12 the number of countries in the region with enhanced monkeypox diagnostic capacity.
Another group of countries in West Africa will receive reagents after participating in a training.
“The geographic spread of monkeypox to parts of Africa where cases have never been detected before is a worrying sign,” said Dr Matshidiso Moeti, WHO Regional Director for Africa.
“It is critical that we support national efforts to boost surveillance and laboratory diagnosis, which are the cornerstones of disease control” Dr Moeti adds.
To deepen analysis of monkeypox transmission patterns, WHO is supporting countries to capitalize on the improved genomic sequencing capacity built during the COVID-19 pandemic.
Currently seven countries can sequence the monkeypox virus.
WHO has reports from South Africa and Nigeria which show the two countries have sequenced 300 samples since January 2022 – these include samples from other countries.
This is more than double all the samples sequenced in previous years.
Most samples sequenced were from the West African clade.
The sequencing done so far shows that there is no recent linkage between what is circulating in Europe and Africa.